# Travere Therapeutics, Inc.: Form 8-K, filed Jan 13, 2026

- Company: [Travere Therapeutics, Inc.](/companies/tvtx.md) (CIK 1438533)
- Form: 8-K
- Filed: 2026-01-13
- Accepted by EDGAR: Jan 13, 2026, 16:32 ET
- Period: 2026-01-13
- Accession: 0001438533-26-000005
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1438533/000143853326000005/tvtx-20260113.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1438533/000143853326000005/

## Items reported

- Item 8.01: Other events

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1438533/000143853326000005/tvtx-20260113.htm

Filed Jan 13, 2026.
Source: SEC EDGAR, the filing index for accession 0001438533-26-000005. Last ingested by Listed: Nov 5, 2026, 14:02 ET. No prices; not investment advice.